These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 34138908)

  • 1. EA3: A softmax algorithm for evidence appraisal aggregation.
    De Pretis F; Landes J
    PLoS One; 2021; 16(6):e0253057. PubMed ID: 34138908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Examining the Use of Real-World Evidence in the Regulatory Process.
    Beaulieu-Jones BK; Finlayson SG; Yuan W; Altman RB; Kohane IS; Prasad V; Yu KH
    Clin Pharmacol Ther; 2020 Apr; 107(4):843-852. PubMed ID: 31562770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Comprehensive Framework for Evaluating the Value Created by Real-World Evidence for Diverse Stakeholders: The Case for Coordinated Registry Networks.
    Gressler LE; Marinac-Dabic D; Resnic FS; Williams S; Yang K; Weichold F; Avila-Tang E; Mack C; Coplan P; Panagiotou OA; Pappas G
    Ther Innov Regul Sci; 2024 Nov; 58(6):1042-1052. PubMed ID: 39060838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of real-world data/evidence in regulatory submissions.
    Song F; Zang C; Ma X; Hu S; Sun Q; Chow SC; Sun H
    Contemp Clin Trials; 2021 Oct; 109():106521. PubMed ID: 34339865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measuring the Effectiveness of Real-World Evidence to Ensure Appropriate Impact.
    Brown JP; Douglas IJ; Hanif S; Thwaites RMA; Bate A
    Value Health; 2021 Sep; 24(9):1241-1244. PubMed ID: 34452702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding Use of Real-World Data and Real-World Evidence to Support Regulatory Decisions on Medical Product Effectiveness.
    Mahendraratnam N; Mercon K; Gill M; Benzing L; McClellan MB
    Clin Pharmacol Ther; 2022 Jan; 111(1):150-154. PubMed ID: 33891318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-World Evidence in the Real World: Beyond the FDA.
    Krause JH; Saver RS
    Am J Law Med; 2018 May; 44(2-3):161-179. PubMed ID: 30106647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Expanding Role of Real-World Evidence Trials in Health Care Decision Making.
    Klonoff DC
    J Diabetes Sci Technol; 2020 Jan; 14(1):174-179. PubMed ID: 30841738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Marketing Authorization Applications Made to the European Medicines Agency in 2018-2019: What was the Contribution of Real-World Evidence?
    Flynn R; Plueschke K; Quinten C; Strassmann V; Duijnhoven RG; Gordillo-Marañon M; Rueckbeil M; Cohet C; Kurz X
    Clin Pharmacol Ther; 2022 Jan; 111(1):90-97. PubMed ID: 34689339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonrandomized Real-World Evidence to Support Regulatory Decision Making: Process for a Randomized Trial Replication Project.
    Franklin JM; Pawar A; Martin D; Glynn RJ; Levenson M; Temple R; Schneeweiss S
    Clin Pharmacol Ther; 2020 Apr; 107(4):817-826. PubMed ID: 31541454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How can real-world evidence aid decision making during the life cycle of nonprescription medicines?
    Csoke E; Landes S; Francis MJ; Ma L; Teotico Pohlhaus D; Anquez-Traxler C
    Clin Transl Sci; 2022 Jan; 15(1):43-54. PubMed ID: 34405554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of RWE to Inform Regulatory, Public Health Policy, and Intervention Priorities for the Developing World.
    McNair D; Lumpkin M; Kern S; Hartman D
    Clin Pharmacol Ther; 2022 Jan; 111(1):44-51. PubMed ID: 34655224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real world evidence (RWE) - a disruptive innovation or the quiet evolution of medical evidence generation?
    Khosla S; White R; Medina J; Ouwens M; Emmas C; Koder T; Male G; Leonard S
    F1000Res; 2018; 7():111. PubMed ID: 30026923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study types and reliability of Real World Evidence compared with experimental evidence used in Polish reimbursement decision-making processes.
    Wilk N; Wierzbicka N; Skrzekowska-Baran I; Moćko P; Tomassy J; Kloc K
    Public Health; 2017 Apr; 145():51-58. PubMed ID: 28359391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Organized structure of real-world evidence best practices: moving from fragmented recommendations to comprehensive guidance.
    Jaksa A; Wu J; Jónsson P; Eichler HG; Vititoe S; Gatto NM
    J Comp Eff Res; 2021 Jun; 10(9):711-731. PubMed ID: 33928789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translational hurdles with cannabis medicines.
    Graham M; Lucas CJ; Schneider J; Martin JH; Hall W
    Pharmacoepidemiol Drug Saf; 2020 Oct; 29(10):1325-1330. PubMed ID: 32281186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing and Interpreting Real-World Evidence Studies: Introductory Points for New Reviewers.
    Wang SV; Schneeweiss S
    Clin Pharmacol Ther; 2022 Jan; 111(1):145-149. PubMed ID: 34416020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving Transparency to Build Trust in Real-World Secondary Data Studies for Hypothesis Testing-Why, What, and How: Recommendations and a Road Map from the Real-World Evidence Transparency Initiative.
    Orsini LS; Berger M; Crown W; Daniel G; Eichler HG; Goettsch W; Graff J; Guerino J; Jonsson P; Lederer NM; Monz B; Mullins CD; Schneeweiss S; Brunt DV; Wang SV; Willke RJ
    Value Health; 2020 Sep; 23(9):1128-1136. PubMed ID: 32940229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of real-world evidence in cancer drug funding decisions in Canada: a qualitative study of stakeholders' perspectives.
    Clausen M; Mighton C; Kiflen R; Sebastian A; Dai WF; Mercer RE; Beca JM; Isaranuwatchai W; Chan KKW; Bombard Y
    CMAJ Open; 2020; 8(4):E772-E778. PubMed ID: 33234584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-world data for health technology assessment for reimbursement decisions in Asia: current landscape and a way forward.
    Lou J; Kc S; Toh KY; Dabak S; Adler A; Ahn J; Bayani DBS; Chan K; Choiphel D; Chua B; Genuino AJ; Guerrero AM; Kearney B; Lin LW; Liu Y; Nakamura R; Pearce F; Prinja S; Pwu RF; Shafie AA; Sui B; Suwantika A; Teerawattananon Y; Tunis S; Wu HM; Zalcberg J; Zhao K; Isaranuwatchai W; Wee HL
    Int J Technol Assess Health Care; 2020 Oct; 36(5):474-480. PubMed ID: 32928330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.